How Can We Help?
Skip to content
Wire frame hand with test tube

Upcoming & Archived Events

Webinar: Underprediction of drug clearance by Aldehyde oxidase (AO)–mediated drug metabolism: Important considerations for in vitro assessment

  • Aug 31, 2021

Aldehyde oxidase (AO) enzyme has gained increasing attention in drug development as one of the alternative approaches to reduce P450-mediated drug metabolism liability. However, clinical…

Webinar: Addressing Unique Challenges with Custom In Vitro Test Systems

  • Jul 27, 2021

Sometimes, standard products just don’t fit the objective of a unique assay. In this webinar, Products Director and custom test...

Webinar: The Role of In Vitro Assays in Selecting the Right Species for Your Small Molecule Program

  • Jun 30, 2021

Choosing the most relevant species for your toxicity studies is critical to ensure your IND provides the relevant data regulators need to advance your program…

Almost Half Off DILI/Hepatotoxicity Studies Until the End of July

  • Jun 15 - Jul 30, 2021

Drug induced liver injury (DILI) or hepatotoxicity is one of the leading causes of adverse events during clinical trials, which...

Webinar: Red Blood Cell Partitioning Studies to Improve Accuracy in Pharmacokinetics (PK) Calculations

  • May 25, 2021
  • Webinar

Pharmacokinetic (PK) parameters of a new drug candidate are typically determined by measuring the drug’s concentration in plasma. However, many drugs have the potential to…

Webinar: An Overview of Non CYP-Mediated Metabolism Pathways and In Vitro Evaluation Strategies

  • Apr 20, 2021
  • Webinar

Although cytochrome P450 (CYP)-mediated metabolism continues to be of major importance for a large proportion of small molecule new drug candidates, various methods in recent…

March 31st DDI Guidance Webinar with Access to a Panel of Drug Metabolism & DDI Experts

  • Mar 31, 2021
  • Webinar

Why should you follow DDI guidance even if you don’t have to? If you missed getting the answer to this question in November 2020 because…

Preclinical DILI Risk Assessment Strategies: Bile Acid-Dependent Hepatotoxicity & Mitochondrial Toxicity Assays

  • Mar 12, 2021
  • Webinar

As part of this year’s SOT Annual Meeting and ToxExpo, we will be including a special presentation as part of...

2C or Not 2C: CYP2C Induction Studies for Successful Preclinical Risk Assessment

  • Mar 2, 2021
  • Webinar

As a part of IND-enabling preclinical drug development studies companies are required to meet regulatory expectations to evaluate the induction...

In Vitro Cholestatic DILI & Mitochondrial Toxicity Studies to Assess Hepatotoxicity

  • Jan 26, 2021

This webinar was presented on Jan. 26, 2021 by Miki Fujishima, a manager in the Business Development Department at the...

Want to see more webinars?

Check out the Webinars page in Access ADME to find upcoming and archived webinars presented by our drug metabolism & DDI experts

Wall of chemical formulas